Genistein was found to inhibit the growth of colorectal cancer stem cells in an animal model of carcinogenesis induced with dimethyl hydrazine, through the down-regulation of CD133/CD44 and the inhibition of the Wnt/β-catenin signaling pathway [144]. Here, PROM1 is linked to colorectal cancer.